---
figid: PMC9646750__gr1
figtitle: Advances in multi-omics study of biomarkers of glycolipid metabolism disorder
organisms:
- Cricetulus griseus
- Mus musculus
- Rattus norvegicus
- Mouse mammary tumor virus
- Diaporthe sclerotioides
- Streptococcus mutans
- Lactococcus lactis subsp. lactis
- Lactobacillus acidophilus
- Lactobacillus gasseri
- Prevotella copri
- Roseburia intestinalis
- Akkermansia muciniphila
- human gut metagenome
- Avena sativa
- gut metagenome
- Bacteroides thetaiotaomicron
- Phocaeicola vulgatus
- Faecalibacterium prausnitzii
- Homo sapiens
organisms_ner:
- Cricetulus griseus
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC9646750
filename: gr1.jpg
figlink: /pmc/articles/PMC9646750/figure/f0005/
number: F1
caption: Genetic variants associated with glycolipid metabolic disorders. a. Overview
  of canonical signaling mechanisms involved in beta-cell glucose sensing and responses
  to secretory potentiators or inhibitors. TCF7L2 (Transcription factor 7-like 2)
  has a role in the canonical Wnt (Wingless-type MMTV integration site) pathway. SLC30A8
  (Solute-linked carrier 30, member 8) encodes ZnT8 (Zinc transporter 8) which regulates
  the influx of zinc into intracellular vesicles of insulin is presumed to be critical
  for insulin storage and secretion. KCNJ11 (K+ inwardly rectifying channel, subfamily
  J, member 11) and SUR1 (Sulfonylurea receptor 1) encode KATP channel together, thus
  indirectly sensing blood glucose concentrations and controlling insulin release.
  PPARs (Peroxisome proliferator-activated receptors) in glycolipid metabolism disorder.
  BAT, brown adipose tissue; FFA, free fatty acids; ROS, reactive oxygen species;
  T2DM, type 2 diabetes mellitus; TG, triglycerides; WAT, white adipose tissue. b.
  Pharmacogenomics and its targets in glycolipid metabolic disorders. MATE1, multidrug
  and toxin extrusion 1; OCT, organic cation transporters; SLC47A1, solute carrier
  family 47 member 1; SUR1, Sulfonylurea receptor 1; KCNJ11, K+ inwardly rectifying
  channel, subfamily J, member 11; ABCC8, ATP-binding cassette, subfamily C, member
  8; GLP-1, glucagon-like peptide-1; GLP-1R, glucagon-like peptide-1 receptor; DPP-4,
  dipeptidyl peptidase-4; SGLT2, sodium-glucose cotransporter 2; MGT, magnesium transporter;
  SLC5A2, solute carrier family 5 member 2; PNPLA3, patatin-like phospholipase domain-containing
  protein 3; MDR1, multidrug resistance gene 1; CYP450, cytochrome P450; HMG-CoA,
  3-hydroxy-3-methylglutaryl coenzyme A.
papertitle: Advances in multi-omics study of biomarkers of glycolipid metabolism disorder.
reftext: Xinyi Fang, et al. Comput Struct Biotechnol J. 2022;20:5935-5951.
year: '2022'
doi: 10.1016/j.csbj.2022.10.030
journal_title: Computational and Structural Biotechnology Journal
journal_nlm_ta: Comput Struct Biotechnol J
publisher_name: Research Network of Computational and Structural Biotechnology
keywords: Multi-omics | Glycolipid metabolism disorder | Biomarkers | Mechanism study
  | 1,5-AG, 1,5-anhydroglucitol | 2-AAA, 2-aminoadipic acid | 2-DGE, two-dimensional
  gel electrophoresis | ABCC8, ATP binding cassette subfamily C member 8 | ADA, American
  Diabetes Association | α-HB, α-hydroxybutyrate | AhR, aromatic hydrocarbon receptor
  | BA, bile acid | BCAA, branched-chain amino acid | BCKAs, branched chain keto acids
  | CE, cholesterol ester | CFL1, cofilin-1 | circRNA, circular RNA | CRP, C reactive
  protein | CYP450, cytochrome P450 | DAG, diacylglycerol | DPP-4, dipeptyl peptidase
  4 | EASD, European Association for the Study of Diabetes | FA, fatty acid | FFA,
  free fatty acid | FMT, fecal microbiota transplantation | FTO, fat mass and obesity-associated
  | GAS5, growth arrest-specific transcript 5 | GC–MS/MS, gas chromatography-tandem
  mass spectrometry | GLP-1, glucagon-like peptide 1 | GLP-1R, glucagon-like peptide
  1 receptor | GSIS, glucose-stimulated insulin secretion | GWAS, genome-wide association
  study | hADCS, human adipose-derived stem cells | HbA1C, glycylated hemoglobin |
  HGF, hepatocyte growth factor | HMG-CoA, hydroxymethylglutaryl-coenzyme A | HMGCR,
  3-hydroxy-methylglutaryl coenzyme A reductase | HPLC, high performance liquid chromatography
  | hsCRP, high-sensitivity C-reactive protein | IL-1ra, interleukin-1 receptor antagonist
  | IMP, imidazole propionate | IR, insulin resistance | JNK, c-Jun-N-terminal-kinase
  | KCNJ11, potassium inwardly rectifying channel subfamily J member 11 | LC-MS/MS,
  liquid chromatography-tandem mass spectrometry | lnc-BATE1, brown adipose tissue
  enriched long non-coding RNA 1 | lncRNA, long non-coding RNA | lncRNA SHGL, lncRNA
  suppressor of hepatic gluconeogenesis and lipogenesis | L-GPC, linoleoyl-glycerophosphocholine
  | LPC, lysophosphatidylcholine | LPE, lysophosphatidylethanolamines | LPS, lipopolysaccharide
  | MAPK, mitogen-activated protein kinase | MASP, mannose-binding lectin-associated
  serine protease 1 | MATE1, multidrug and toxin extrusion protein 1 | MDR1, multidrug
  resistance mutation 1 | MGT, magnesium transporter | miRNA, micro RNA | mRNA, messenger
  RNAs | MS, Mass Spectrometry | mTORC1, mechanistic target of rapamycin complex 1
  | ncRNA, non-coding RNA | NK, natural killer | NMR, nuclear magnetic resonance |
  OCT, organic cationic transporter | OGTT, oral glucose tolerance test | PC-PL, phosphatidylcholine-plasmalogen
  | PE, phosphatidylethanolamines | PNPLA3, patatin-like phospholipase domain-containing
  protein 3 | PPAR, peroxisome proliferator-activated receptor | PTBP1, polypyrimidine
  tract-binding protein 1 | PTP, protein tyrosine phosphatase | RNS, reactive nitrogen
  species | ROS, reactive oxygen species | SCFA, short-chain fatty acid | SLC30A8,
  solute carrier family 30 member 8 | SLC47A1, solute carrier family 47 member 1 |
  SLC5A2, solute carrier family 5 member 2 | SM, sphingomyelin | SNP, single-nucleotide
  polymorphism | SSPG, steady-state plasma glucose | SUR1, sulfonylurea receptor 1
  | T2DM, type 2 diabetes mellitus | TAG, triacylglycerol | TCA, tricarboxylic acid
  | TCF7L2, transcription factor 7-like 2 | TF, transcription factor | TMA, trimethylamine
  | TMAO, trimethylamine oxide | TNF-α, tumor necrosis factor alpha | TOF-MS, time-of-flight
  mass spectrum | t-PA, tissue plasminogen activator | TUG1, taurine upregulated gene
  1 | USP20, ubiquitin-specificpeptidase 20 | WBC, white blood cell
automl_pathway: 0.9313674
figid_alias: PMC9646750__F1
figtype: Figure
redirect_from: /figures/PMC9646750__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9646750__gr1.html
  '@type': Dataset
  description: Genetic variants associated with glycolipid metabolic disorders. a.
    Overview of canonical signaling mechanisms involved in beta-cell glucose sensing
    and responses to secretory potentiators or inhibitors. TCF7L2 (Transcription factor
    7-like 2) has a role in the canonical Wnt (Wingless-type MMTV integration site)
    pathway. SLC30A8 (Solute-linked carrier 30, member 8) encodes ZnT8 (Zinc transporter 8)
    which regulates the influx of zinc into intracellular vesicles of insulin is presumed
    to be critical for insulin storage and secretion. KCNJ11 (K+ inwardly rectifying
    channel, subfamily J, member 11) and SUR1 (Sulfonylurea receptor 1) encode KATP
    channel together, thus indirectly sensing blood glucose concentrations and controlling
    insulin release. PPARs (Peroxisome proliferator-activated receptors) in glycolipid
    metabolism disorder. BAT, brown adipose tissue; FFA, free fatty acids; ROS, reactive
    oxygen species; T2DM, type 2 diabetes mellitus; TG, triglycerides; WAT, white
    adipose tissue. b. Pharmacogenomics and its targets in glycolipid metabolic disorders.
    MATE1, multidrug and toxin extrusion 1; OCT, organic cation transporters; SLC47A1,
    solute carrier family 47 member 1; SUR1, Sulfonylurea receptor 1; KCNJ11, K+ inwardly
    rectifying channel, subfamily J, member 11; ABCC8, ATP-binding cassette, subfamily
    C, member 8; GLP-1, glucagon-like peptide-1; GLP-1R, glucagon-like peptide-1 receptor;
    DPP-4, dipeptidyl peptidase-4; SGLT2, sodium-glucose cotransporter 2; MGT, magnesium
    transporter; SLC5A2, solute carrier family 5 member 2; PNPLA3, patatin-like phospholipase
    domain-containing protein 3; MDR1, multidrug resistance gene 1; CYP450, cytochrome
    P450; HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ctnnb1
  - Tcf7l2
  - Kcnj11
  - Dpp4
  - Glp1r
  - Slc5a2
  - Pnpla3
  - Abcc8
  - Slc30a8
  - Wnt2
  - Axin1
  - Slc2a2
  - Slc47a1
  - Gcg
  - Abcb1b
  - Plxna3
  - Defa5
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AXIN1
  - AXIN2
  - CTNNB1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - TCF7L2
  - SLC2A2
  - ATP8A2
  - KCNJ11
  - SLC47A1
  - PLXNA2
  - SLC5A2
  - DPP4
  - SLC30A8
  - GCG
  - GLP1R
  - ZGLP1
  - ZBTB20
  - BAAT
  - IRF1
  - ABCB1
  - TBC1D9
  - PNPLA3
  - ABCC8
  - Plxna2
  - Zbtb20
  - Baat
  - D7Zem4
  - Rtl1
  - Mod2
  - ctnnb1
  - kita
  - ngfra
  - tcf7l2
  - slc2a2
  - kcnj11
  - dpp4
  - slc47a1
  - slc47a2.1
  - foxb1a
  - abcb5
  - slc5a2
  - pnpla3
  - abcc8
  - slc30a8
  - Glucose
  - ATP
  - ATP ATP
  - Metformin
  - Sulfonylureas
  - Ca2+
  - ZnT
  - Zn2
  - Zn2+
  - Glucose  Glucose 6P
  - Glucose metabolism
  - WAT
---
